Gem Aromatics IPO : GMP, price band, key dates and more
- Krishna Priya
- Aug 16
- 2 min read
The company has set a price band of ₹309–₹325 per share, and retail investors can apply for as few as 46 shares, requiring a minimum investment of ₹14,950 at the upper price band.
IPO Snapshot
Detail | Information |
Total Issue Size | ₹451.25 Cr |
Fresh Issue | ₹175.00 Cr |
Offer for Sale | ₹276.25 Cr |
Price Band | ₹309 – ₹325 per share |
Lot Size | 46 shares |
Minimum Investment | ₹14,950 (at upper band) |
Listing | NSE & BSE |
IPO Opens | August 19, 2025 |
IPO Closes | August 21, 2025 |
Incorporated in 1997, Gem Aromatics Limited manufactures essential oils, aroma chemicals, and value-added derivatives for sectors like oral care, cosmetics, nutraceuticals, and pharmaceuticals. Serving 225 customers across 18 countries, the company leverages its US subsidiary, global partnerships, and a 13-member R&D team to drive innovation and exports.
Financial Performance
Period Ended | Revenue (₹ Cr) | Profit After Tax (PAT) (₹ Cr) |
31 Mar 2025 | 503.95 | 53.38 |
31 Mar 2024 | 452.42 | 50.10 |
31 Mar 2023 | 424.79 | 44.67 |
Grey Market Premium (GMP)
As of now, the Grey Market Premium (GMP) for Gem Aromatics IPO stands at ₹41. Based on the upper price band of ₹325, the estimated listing price is ₹366, indicating an expected gain of 12.62% per share.
Peer comparison
Company Name | CMP (₹) | Mkt Cap (₹ Cr) | P/E | Sales (₹ Cr) | OPM % | PAT 12M (₹ Cr) |
Gem Aromatics | — | — | — | 503.95 | — | 53.38 |
Clean Science | 1210.00 | 12,858.34 | 43.34 | 924.92 | 43.46 | 296.73 |
Privi Speciality | 2403.10 | 9,387.15 | 44.58 | 2,196.02 | 22.21 | 210.80 |
Camlin Fine Sciences | 205.00 | 3,852.39 | 99.63 | 1,715.00 | 10.36 | -134.16 |
Yasho Industries | 1736.00 | 2,093.11 | 171.42 | 696.26 | 17.71 | 12.21 |
S H Kelkar & Co. | 222.85 | 3,084.69 | 23.60 | 2,233.72 | 12.99 | 185.38 |
Oriental Aromatics | 329.85 | 1,110.05 | 46.57 | 938.02 | 9.43 | 23.84 |
Use of Proceeds
The net proceeds from the IPO will be utilised towards prepayment and/or repayment of certain outstanding borrowings of the company and its subsidiary, Krystal Ingredients Private Limited, amounting to ₹140 crore, with the balance earmarked for general corporate purposes.
Disclaimer: This content is for educational purposes only; please conduct your own research and consult with a qualified investment advisor before making any investment decisions.
Want to read more?
Subscribe to finsightsbysquareleague.com to keep reading this exclusive post.
